News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
Presentation ESC 2024 OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation Presenter: Manesh R. Patel September 01, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study Todd Neale July 05, 2024
News Conference News NY Valves 2024 Leaks After LAAO Do Matter, Experts Agree Todd Neale June 10, 2024
News Daily News Potential Contributors to ESUS Explored in New Consensus Statement Todd Neale May 14, 2024
News Conference News EHRA 2024 Stroke Rates Fall Among AF Patients Not on Anticoagulation Todd Neale April 11, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News ISC 2024 Speedier Anticoagulation Reversal Tied to Better ICH Outcomes Todd Neale February 15, 2024
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023